Review article · 2024 · Open access
Engineered exosomes as a prospective therapy for diabetic foot ulcers
Burns & Trauma, 12, tkae023 · Published 1 January 2024 · DOI 10.1093/burnst/tkae023
In brief
“Engineered exosomes as a prospective therapy for diabetic foot ulcers” is a 2024 review article by Lifei Guo and 4 co-authors, published in Burns & Trauma. OpenAlex counts 43 citations as of 19 November 2026, which puts it in the top 4% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at Burns & Trauma.
- Citations
- 43
- Most cited in
- 2026 (21)
- Field-weighted impact
- 1.47
- References
- 281
- Authors
- 5
Abstract
Diabetic foot ulcer (DFU), characterized by high recurrence rate, amputations and mortality, poses a significant challenge in diabetes management. The complex pathology involves dysregulated glucose homeostasis leading to systemic and local microenvironmental complications, including peripheral neuropathy, micro- and macro-angiopathy, recurrent infection, persistent inflammation and dysregulated re-epithelialization. Novel approaches to accelerate DFU healing are actively pursued, with a focus on utilizing exosomes. Exosomes are natural nanovesicles mediating cellular communication and containing diverse functional molecular cargos, including DNA, mRNA, microRNA (miRNA), lncRNA, proteins, lipids and metabolites. While some exosomes show promise in modulating cellular function and promoting ulcer healing, their efficacy is limited by low yield, impurities, low loading content and inadequate targeting. Engineering exosomes to enhance their curative activity represents a potentially more efficient approach for DFUs. This could facilitate focused repair and regeneration of nerves, blood vessels and soft tissue after ulcer development. This review provides an overview of DFU pathogenesis, strategies for exosome engineering and the targeted therapeutic application of engineered exosomes in addressing critical pathological changes associated with DFUs.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Guo, L., Xiao, D., Xing, H., Yang, G., & Yang, X. (2024). Engineered exosomes as a prospective therapy for diabetic foot ulcers. Burns & Trauma, 12, tkae023. https://doi.org/10.1093/burnst/tkae023
MLA 9
Guo, Lifei, et al. “Engineered exosomes as a prospective therapy for diabetic foot ulcers.” Burns & Trauma, vol. 12, 2024, p. tkae023. https://doi.org/10.1093/burnst/tkae023.
Chicago
Guo, Lifei, Dan Xiao, Helin Xing, Guodong Yang, and Xuekang Yang. 2024. “Engineered exosomes as a prospective therapy for diabetic foot ulcers.” Burns & Trauma 12: tkae023. https://doi.org/10.1093/burnst/tkae023.
Harvard
Guo, L. et al. (2024) ‘Engineered exosomes as a prospective therapy for diabetic foot ulcers’, Burns & Trauma, 12, p. tkae023. doi:10.1093/burnst/tkae023.
IEEE
L. Guo, D. Xiao, H. Xing, G. Yang, and X. Yang, “Engineered exosomes as a prospective therapy for diabetic foot ulcers,” Burns & Trauma, vol. 12, p. tkae023, 2024, doi: 10.1093/burnst/tkae023.
BibTeX
@article{guo2024engineered,
title = {{Engineered exosomes as a prospective therapy for diabetic foot ulcers}},
author = {Guo, Lifei and Xiao, Dan and Xing, Helin and Yang, Guodong and Yang, Xuekang},
journal = {Burns \& Trauma},
year = {2024},
volume = {12},
pages = {tkae023},
doi = {10.1093/burnst/tkae023},
url = {https://doi.org/10.1093/burnst/tkae023}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 4 | |
| 2025 | 18 | |
| 2026 | 21 |
Its field-weighted citation impact is 1.47: it has been cited 1.47 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- diabetic foot ulcer
- engineered exosomes
- exosome engineering
- wound healing
- peripheral neuropathy
- angiopathy
- microangiopathy
- re-epithelialization
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Guo, L., Xiao, D., Xing, H., Yang, G., & Yang, X. (2024). Engineered exosomes as a prospective therapy for diabetic foot ulcers. Burns & Trauma, 12, tkae023. https://doi.org/10.1093/burnst/tkae023
How many times has this paper been cited?
43 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Burns & Trauma: sign in and open the full text from this page.
Who wrote this paper?
Lifei Guo, Dan Xiao, Helin Xing, Guodong Yang, Xuekang Yang.
What is the DOI of this paper?
10.1093/burnst/tkae023, permanently at https://doi.org/10.1093/burnst/tkae023. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.